High Roller Technologies, Inc. rose 5.32% in after-hours trading. The company's stock price increase aligns with the positive news of Kairos Pharma announcing positive safety results from phase 2 trial of ENV-105 in advanced prostate cancer, which led to a 64.21% increase in its stock price. Additionally, MP Materials Corp. saw a 22.10% increase in its stock price due to the news that the US rare earth pricing system is poised to challenge China's dominance.
Comments
No comments yet